Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.

Source:http://linkedlifedata.com/resource/pubmed/id/21303974

Cancer Res. 2011 Feb 15 71 4 1454-64

Download in:

View as

General Info

PMID
21303974